PATENT CLAIM ANALYSIS

Application Number: 15777952
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "464000"]

Abstract:
A pharmaceutical composition comprising clobazam or its pharmaceutically acceptable salt(s) or solvate(s) thereof of defined particle size and one or more pharmaceutically acceptable excipients is described. A method for preparing the composition is also described.

Claim (Index 8):
The pharmaceutical composition as claimed in  claim 6 , wherein the said diluent is selected from the group consisting of lactose monohydrate, sucrose, dextrose, mannose, fructose, galactose sugar-alcohols such as sorbitol, mannitol, erythritol, xylitol, lactitol, starlac, starch, pregelatinized starch, dibasic calcium phosphate, tribasic calcium phosphate, calcium carbonate, calcium sulfate, powdered cellulose, microcrystalline cellulose, silicified microcrystalline cellulose, magnesium carbonate, magnesium oxide, magnesium alumino metasilicate and/or a combination thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.3871
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11238496', '11776012', '11527501', '13422494', '14917125']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7730488326648426
- 35 USC 102 Novelty (BERT): 0.4848943712438656
- Combined Prediction Score: 0.744233386522745
- Mean Citation Score: 234.973662
- Max Citation Score: 257.56058
- Similarity Product: 231.3575019465733

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test